Senesco Technologies (SNT)
Senesco Technologies Revenues: 0.20M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SNT Revenues Rankings
| Overall | 1st percentile | 4378 of 4431 |
| Sector | 5th percentile | 445 of 471 in Healthcare |
| Industry | 10th percentile | 118 of 132 in Biotechnology |
SNT Revenues Range, Past 5 Years
| Minimum | 0.004M | Jun 2008 |
| Maximum | 0.371M | Sep 2007 |
| Average | 0.1229M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these SNT related companies
SNT News
Senesco’s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma
May 23, 8:30AM Business Wire
May 23, 8:30AM Business Wire
Senesco Adds Additional Clinical Site to Evaluate SNS01-T in Multiple Myeloma
Mar 07, 8:30AM Business Wire
Mar 07, 8:30AM Business Wire
Senesco Adds Second Clinical Site to Evaluate SNS01-T in Multiple Myeloma
Mar 01, 8:30AM Business Wire
Mar 01, 8:30AM Business Wire
Senesco Technologies Reports Second Quarter Fiscal 2012 Financial Results
Feb 15, 8:30AM Business Wire
Feb 15, 8:30AM Business Wire
Senesco Announces $2.0 Million Equity Financing; Selling 7.69M Common Stock at $0.286/Share
Jan 09, 8:32AM Benzinga
Jan 09, 8:32AM Benzinga
Senesco to Present at the 53rd Annual Meeting of the American Society of Hematology on SNS01-T
Dec 06, 9:24AM Business Wire
Dec 06, 9:24AM Business Wire
Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
Nov 29, 3:54PM PR Newswire
Nov 29, 3:54PM PR Newswire
Senesco to Present at NYSSA's 2011 Biotech / Specialty Pharma Conference
Nov 22, 8:30AM Business Wire
Nov 22, 8:30AM Business Wire
Senesco Technologies Reports First Quarter Fiscal 2012 Financial Results
Nov 15, 8:30AM Business Wire
Nov 15, 8:30AM Business Wire
$SNT filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/uML
about 213 days ago by MarketBrief
about 213 days ago by MarketBrief
$SNT http://chart.ly/h39haqq pennystock on long scan half dozen times past few months, see $0.50 as possibility
about 330 days ago by traderdigs
about 330 days ago by traderdigs
Senesco $SNT Says FDA Removes Clinical Holds for IND Application on SNS01-T
about 347 days ago by Street_Insider
about 347 days ago by Street_Insider
http://schrts.com/eQsR4t SNT - $SNT super consolidation pattern, volume and action.... sub 1 tho so be aware
about 511 days ago by stt2318
about 511 days ago by stt2318
Own 20K shares of $LWLG and counting....and 10K of $SNT That's all. You'll get the $LWLG one day
about 612 days ago by ggthomas58
about 612 days ago by ggthomas58
15K of $SNT penny stock to hold till I make money long, short or whatever
about 616 days ago by ggthomas58
about 616 days ago by ggthomas58
Will see this guy can move $SNT also .. >> http://seekingalpha.com/article/226003-update-on-savient-chelsea-therapeutics
about 619 days ago by ggthomas58
about 619 days ago by ggthomas58
RT @TradeHawk: Peter Navarro who lit $CHTP on CNBC Friday out on Seeking Alpha saying a profile on $SNT is coming soon. http://bit.ly/b ...
about 620 days ago by ggthomas58
about 620 days ago by ggthomas58
$SNT Hearing share strength attributable to positive comments from TheStreet.com's Peter Navarro -who brought us $CHTP on Fri. ill take 20
about 620 days ago by hitthebid01
about 620 days ago by hitthebid01
Peter Navarro who lit $CHTP on CNBC Friday out on Seeking Alpha saying a profile on $SNT is coming soon. http://bit.ly/bcbj5o
about 620 days ago by TradeHawk
about 620 days ago by TradeHawk
$SNT cruce por encima de media de 50dias, possible movida a
por la zona de 0.70 - 0.75
about 718 days ago by Alphalobotrade
about 718 days ago by Alphalobotrade
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SNT | 0.245 | +0.01 | +6.52% | 21.13M |
| SGU | 3.93 | -0.02 | -0.51% | 242.14M |
| SGRP | 1.24 | +0.00 | +0.00% | 24.92M |
| SGOL | 160.51 | +5.92 | +3.83% | |
| SGNT | 15.98 | +0.03 | +0.19% | 444.69M |
| SGMS | 8.20 | -0.34 | -3.98% | 790.29M |
| SGMO | 4.23 | -0.21 | -4.73% | 233.37M |
| SGMA | 3.77 | -0.03 | -0.79% | 14.86M |
| SGK | 10.66 | -0.49 | -4.39% | 287.22M |
| SGI | 5.55 | -0.34 | -5.77% | 186.36M |
